Otsuka Holdings Co., Ltd. (OTSKY)
OTCMKTS · Delayed Price · Currency is USD
32.80
+0.95 (2.98%)
At close: Mar 4, 2026
Otsuka Holdings Market Cap
Otsuka Holdings has a market cap or net worth of $34.19 billion as of March 5, 2026. Its market cap has increased by 21.53% in one year.
Market Cap
34.19B
Enterprise Value
32.66B
Revenue
15.75B
Ranking
n/a
PE Ratio
14.76
Stock Price
$32.80
Market Cap Chart
Since December 15, 2010, Otsuka Holdings's market cap has increased from 12.15B to 34.19B, an increase of 181.47%. That is a compound annual growth rate of 7.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 33.73B | 12.47% |
| Dec 30, 2025 | 29.99B | 2.03% |
| Dec 30, 2024 | 29.39B | 44.33% |
| Dec 29, 2023 | 20.36B | 14.95% |
| Dec 30, 2022 | 17.71B | -9.80% |
| Dec 30, 2021 | 19.64B | -15.33% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 791.42M |
| Veradigm | 724.25M |
| Glass House Brands | 659.67M |
| Elite Pharmaceuticals | 420.20M |
| American Oncology Network | 389.18M |
| Northwest Biotherapeutics | 361.40M |
| CytoDyn | 310.14M |
| Silence Therapeutics | 273.01M |